Trends and Effect of Marginalization on Diabetes Mellitus-related Mortality in Mexico from 1990 to 2019

Overview

Journal Sci Rep

Specialty Science

Date 2022 Jun 2

PMID 35654853

Authors

Eduardo Gutierrez-Leon

Ricardo Antonio Escamilla-Santiago

Pablo Martinez-Amezcua

Usama Bilal

Mariana Lazo

Rafael Ogaz-Gonzalez

Malaquias Lopez-Cervantes

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus (DM) is currently one of the leading causes of mortality worldwide. However, the disease evolves differently across countries. This study intends to characterize the trends and assess the potential effects of marginalization on DM mortality between 1990 and 2019 in Mexico. We analyzed death certificates that listed DM as the underlying cause of death (N = 1,907,173), as well as the extent to which DM mortality changes were associated with marginalization through an age-period-cohort analysis. DM mortality increased in Mexico between 1990 and 2019; the change was faster in the first half and slowed down after 2004. The highest marginalization quintiles drove the changes in DM mortality trends during the study period, with a higher risk of dying in these quintiles as age increased. In recent cohorts, the highest marginalization quintiles doubled the risk of dying from DM as compared to the lowest. Renal complications was the main death driver among persons with DM, with a marked increase between 1999 and 2001. In conclusion, Mexico continues to have a substantially high DM mortality, but its pace slowed over time. Moreover, subnational differences in marginalization can partially explain such a trend.

Citing Articles

Mortality from type 2 diabetes mellitus across municipalities in Mexico.

Cervantes C, Baptista E Arch Public Health. 2024; 82(1):196.

PMID: 39478615 PMC: 11523589. DOI: 10.1186/s13690-024-01432-z.

The burden of type 2 diabetes in adolescents and young adults in Mexico: analysis from the Global Burden of Disease Study, 1990 to 2019.

Davila-Cervantes C J Diabetes Metab Disord. 2023; 22(2):1673-1684.

PMID: 37975094 PMC: 10638125. DOI: 10.1007/s40200-023-01299-x.

Type 2 diabetes and depressive symptoms in the adult population in Mexico: a syndemic approach based on National Health and Nutrition Survey.

Agudelo-Botero M, Giraldo-Rodriguez L, Davila-Cervantes C BMC Public Health. 2022; 22(1):2049.

PMID: 36352364 PMC: 9643915. DOI: 10.1186/s12889-022-14405-0.

Bello-Chavolla O, Antonio-Villa N, Fermin-Martinez C, Fernandez-Chirino L, Vargas-Vazquez A, Ramirez-Garcia D Diabetes Care. 2022; 45(12):2957-2966.

PMID: 36286591 PMC: 7613876. DOI: 10.2337/dc22-0616.

References

Helmrich S, Ragland D, Leung R, Paffenbarger Jr R . Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991; 325(3):147-52. DOI: 10.1056/NEJM199107183250302. View

Alegre-Diaz J, Herrington W, Lopez-Cervantes M, Gnatiuc L, Ramirez R, Hill M . Diabetes and Cause-Specific Mortality in Mexico City. N Engl J Med. 2016; 375(20):1961-1971. PMC: 5215048. DOI: 10.1056/NEJMoa1605368. View

Bello-Chavolla O, Rojas-Martinez R, Aguilar-Salinas C, Hernandez-Avila M . Epidemiology of diabetes mellitus in Mexico. Nutr Rev. 2017; 75(suppl 1):4-12. DOI: 10.1093/nutrit/nuw030. View

Ma J, Ward E, Siegel R, Jemal A . Temporal Trends in Mortality in the United States, 1969-2013. JAMA. 2015; 314(16):1731-9. DOI: 10.1001/jama.2015.12319. View

. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. PMC: 5605509. DOI: 10.1016/S0140-6736(17)32154-2. View

Ogurtsova K, da Rocha Fernandes J, Huang Y, Linnenkamp U, Guariguata L, Cho N . IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40-50. DOI: 10.1016/j.diabres.2017.03.024. View

Holford T . The estimation of age, period and cohort effects for vital rates. Biometrics. 1983; 39(2):311-24. View

Gregg E, Li Y, Wang J, Burrows N, Ali M, Rolka D . Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014; 370(16):1514-23. DOI: 10.1056/NEJMoa1310799. View

Orozco-Beltran D, Sanchez E, Garrido A, Quesada J, Carratala-Munuera M, Gil-Guillen V . Trends in Mortality From Diabetes Mellitus in Spain: 1998-2013. Rev Esp Cardiol (Engl Ed). 2016; 70(6):433-443. DOI: 10.1016/j.rec.2016.09.022. View

10.

Mikkelsen L, Phillips D, AbouZahr C, Setel P, de Savigny D, Lozano R . A global assessment of civil registration and vital statistics systems: monitoring data quality and progress. Lancet. 2015; 386(10001):1395-1406. DOI: 10.1016/S0140-6736(15)60171-4. View

11.

Tiwari R, Clegg L, Zou Z . Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2007; 15(6):547-69. DOI: 10.1177/0962280206070621. View

12.

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

13.

Li Y, Kou C, Bai W, Hua W, Yu W, Song Y . Trends in Diabetes Mortality by Gender in Urban and Rural Areas in China From 2003 to 2012: An Age-Period-Cohort Analysis. Asia Pac J Public Health. 2019; 31(3):238-245. DOI: 10.1177/1010539519841288. View

14.

Meza R, Barrientos-Gutierrez T, Rojas-Martinez R, Reynoso-Noveron N, Palacio-Mejia L, Lazcano-Ponce E . Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates. Prev Med. 2015; 81:445-50. PMC: 4679631. DOI: 10.1016/j.ypmed.2015.10.015. View

15.

Malta D, Franca E, Abreu D, Perillo R, Salmen M, Teixeira R . Mortality due to noncommunicable diseases in Brazil, 1990 to 2015, according to estimates from the Global Burden of Disease study. Sao Paulo Med J. 2017; 135(3):213-221. PMC: 10019842. DOI: 10.1590/1516-3180.2016.0330050117. View

16.

Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-281. DOI: 10.1016/j.diabres.2018.02.023. View

17.

Aguilar-Ramirez D, Alegre-Diaz J, Gnatiuc L, Ramirez-Reyes R, Wade R, Hill M . Changes in the Diagnosis and Management of Diabetes in Mexico City Between 1998-2004 and 2015-2019. Diabetes Care. 2021; 44(4):944-951. PMC: 7985415. DOI: 10.2337/dc20-2276. View

18.

. 6. Glycemic Targets: . Diabetes Care. 2019; 43(Suppl 1):S66-S76. DOI: 10.2337/dc20-S006. View

19.

Liu X, Yu C, Wang Y, Bi Y, Liu Y, Zhang Z . Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: A Joinpoint and Age-Period-Cohort Analysis. Int J Environ Res Public Health. 2019; 16(1). PMC: 6339039. DOI: 10.3390/ijerph16010158. View

20.

Carstensen B . Age-period-cohort models for the Lexis diagram. Stat Med. 2006; 26(15):3018-45. DOI: 10.1002/sim.2764. View